TRENBOLONE ACETATE (100 MG/ML – 10 ML)
Trenbolone Acetate 100 is an oil-based sterile injectable solution containing trenbolone acetate at a strength of 100 mg/ml. The formulation is intended for intramuscular administration and contains trenbolone acetate as its active ingredient. According to the supplied product information, the product is classified as a prescription medicine and is manufactured by Hilma Biocare.
Trenbolone is a synthetic anabolic-androgenic steroid related pharmacologically to testosterone. It binds strongly to androgen receptors and can influence androgen-dependent physiological processes. The supplied clinical pharmacology information describes effects involving protein synthesis, nitrogen retention, muscle tissue metabolism, and endogenous hormone regulation. As with other exogenous anabolic-androgenic steroids, administration can suppress the normal production of endogenous testosterone through feedback effects on pituitary luteinising hormone and may suppress spermatogenesis at higher exposure levels.
Trenbolone acetate is described as a fast-acting ester. Following intramuscular administration, the ester is intended to provide a relatively rapid increase in circulating trenbolone levels, followed by a decline over the subsequent days. The supplied information also discusses possible interactions with androgen, progesterone, and prolactin receptor pathways. Because these mechanisms can affect endocrine function, appropriate clinical assessment and monitoring are important when treatment is medically considered.
The product information identifies several potential adverse reactions. These include acne, hirsutism, male-pattern hair loss, changes in libido, gynecomastia, oligospermia, fluid and electrolyte retention, nausea, changes in liver function, and alterations in serum lipid levels. Neurological and psychological effects listed in the supplied information include headache, anxiety, depression, irritability, agitation, and potentially severe changes in aggressive behaviour. Other reported effects include hypertension, oedema, hypercalcaemia, priapism, and potentiation of sleep apnoea.
Trenbolone may also affect cardiovascular, hepatic, metabolic, and reproductive parameters. The supplied information advises particular caution in patients with cardiovascular disease and identifies potential concerns involving cholesterol levels, liver function, blood pressure, and reproductive hormone regulation. Patients receiving androgenic therapy may require appropriate laboratory and clinical monitoring according to the judgement of their healthcare professional.
The supplied contraindications include hypersensitivity to the ingredients and known or suspected carcinomas of the breast, testis, or prostate. The information also lists severe heart disease, liver disease, kidney disease, and a history of epilepsy among contraindications. It states that androgen-containing products should not be used in women because of the potential for virilisation and fetal harm.
Potential drug interactions are also described. Patients receiving oral anticoagulants require appropriate monitoring because androgenic steroids may affect anticoagulant response. The supplied information also notes possible effects on the metabolism of oral hypoglycaemic medicines and cyclosporine. Concomitant use of other hepatotoxic medicines is identified as a concern.
Patient monitoring described in the supplied information includes serum cholesterol, HDL, LDL and triglycerides, haemoglobin and haematocrit, hepatic function tests such as AST and ALT, testosterone, dihydrotestosterone, estradiol, progesterone, prolactin, and blood pressure. Prostate-related assessment, including PSA evaluation, is also described where clinically appropriate.
Product Details:
Strength: 100 mg/ml
Active Ingredient: Trenbolone acetate
Molecular Formula: C20H24O3
Molecular Weight: 312.40276 g/mol
CAS Number: 10161-34-9
Dosage Form: Injectable, oil-based sterile solution
Route: Intramuscular injection
Market Status: Prescription
Company: Hilma Biocare
Strength: 100 mg/ml
Active Ingredient: Trenbolone acetate
Molecular Formula: C20H24O3
Molecular Weight: 312.40276 g/mol
CAS Number: 10161-34-9
Dosage Form: Injectable, oil-based sterile solution
Route: Intramuscular injection
Market Status: Prescription
Company: Hilma Biocare
Presentation:
Trenbolone Acetate 100 mg/ml, 10 ml multiple-dose vial.
Storage:
Store in a cool, dry place between 15–25°C. Protect from light.
Important:
This product should only be used under the supervision of a qualified healthcare professional. The supplied product information contains a dosage regimen, but individual treatment decisions should be made by an appropriately qualified physician based on the patient’s clinical circumstances.
